Skip to main content
NCBI home page
The Canadian Veterinary Journal logoLink to The Canadian Veterinary Journal
. 1992 Sep;33(9):612–613.

Human recombinant erythropoietin therapy in a cat with chronic renal failure

Roselle M Bloomberg, Harold A Pook, Robert M Jacobs, Julian M Van Gorder
PMCID: PMC1481339  PMID: 17424079

Full text

PDF
612

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adamson J. W., Eschbach J. W. Treatment of the anemia of chronic renal failure with recombinant human erythropoietin. Annu Rev Med. 1990;41:349–360. doi: 10.1146/annurev.me.41.020190.002025. [DOI] [PubMed] [Google Scholar]
  2. Castaldi P. A., Rozenberg M. C., Stewart J. H. The bleeding disorder of uraemia. A qualitative platelet defect. Lancet. 1966 Jul 9;2(7454):66–69. doi: 10.1016/s0140-6736(66)91802-2. [DOI] [PubMed] [Google Scholar]
  3. Eschbach J. W., Adamson J. W. Guidelines for recombinant human erythropoietin therapy. Am J Kidney Dis. 1989 Aug;14(2 Suppl 1):2–8. [PubMed] [Google Scholar]
  4. Krantz S. B. Review of patients' responses to epoetin alfa therapy. Pharmacotherapy. 1990 Mar-Apr;10(2 ):15S–21S. [PubMed] [Google Scholar]
  5. Shaw A. B. Haemolysis in chronic renal failure. Br Med J. 1967 Apr 22;2(5546):213–216. doi: 10.1136/bmj.2.5546.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Van Wyck D. B. Iron management during recombinant human erythropoietin therapy. Am J Kidney Dis. 1989 Aug;14(2 Suppl 1):9–13. [PubMed] [Google Scholar]

Articles from The Canadian Veterinary Journal are provided here courtesy of Canadian Veterinary Medical Association

RESOURCES